Professor Colin Dayan



Prosiectau fel Prif Ymchwiliwr
null null 7 o 7 null null

Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger smarter faster - Cyllidwr:Juvenile Diabetic Research Foundation, - Cyllidwr:Diabetes UK (01.05.2019 - 30.04.2022)
The beta-2 score and beyond: new composite outcomes measures of islet cell function for use in clinical trials - Cyllidwr:Juvenile Diabetic Research Foundation (01.10.2019 - 30.09.2022)
Reducing the impact of diabetic foot ulcers on patients and the health service: The REDUCE programme - Cyllidwr:National Institute for Health Research (01.03.2020 - 31.12.2025)


Prosiectau fel Cyd-Ymchwiliwr
null null 3 o 3 null null

Pregnancy outcomes in women diagnosed with type 1 diabetes mellitus in childhood: A national population-based study - Cyllidwr:Diabetes Research & Wellness Foundation (01.02.2017 - 30.04.2018)
A new window into the immune response funding during Type 1 Diabetes - Cyllidwr:Wellcome Trust (01.11.2017 - 31.05.2019)
Bringing immunotherapy for type 1 diabetes into the clinic: New windows into the immune response - Cyllidwr:Diabetes Research & Wellness Foundation (01.05.2018 - 30.04.2019)
Regulation of HAS2 transcription relevant to Graves orbitopathy (GO) - Cyllidwr:National Eye Research Centre (01.08.2011 - 31.12.2013)

Diweddarwyd y tro diwethaf ar 2020-09-08 am 04:07